Able Wealth Management
ABBV icon

Able Wealth Management’s AbbVie ABBV Stock Holding History

Able Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$313K Sell
1,180
-137
-10% -$35.1K 0.07% 103
2026
Q2 		$332K Buy
+1,317
New +$283K 0.08% 104
2024
Q1 		– Sell
-213
Closed -$33K – 90
2023
Q4 		$33K Buy
+213
New +$31.1K 0.03% 162

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Able Wealth Management's ABBV Position: Q3 2026 in Review

Able Wealth Management reduced its AbbVie (ABBV) stake by 10% in Q3 2026, selling an estimated $35.1K and leaving 1,180 shares worth $313K. The position accounts for 0.07% of the portfolio, ranked #103.

Able Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 3 quarters since. The position peaked at $332K in Q2 2026. 1,551 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Able Wealth Management held 1,180 shares of AbbVie worth $313K as of Q3 2026.
  • Able Wealth Management sold 137 AbbVie shares in Q3 2026, an estimated $35.1K.
  • AbbVie made up 0.07% of Able Wealth Management's portfolio in Q3 2026, its #103 holding.
  • Able Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 3 quarters since.
  • Able Wealth Management's AbbVie position peaked at $332K in Q2 2026.
  • 1,551 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Able Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.